Beyond the pipeline: Investing in the tools and tech powering CGT

As investors recalibrate their strategies in the CGT sector, attention is shifting beyond therapeutic developers to the tools, platforms and enabling technologies that underpin the industry. These companies, spanning automation, analytics and manufacturing systems, are becoming the backbone of CGT progress. In this fireside chat, explore how investors are identifying value in the infrastructure layer of advanced therapies, and why tools and tech providers may be an opportunity for long-term growth.

Key takeaways

• Why tools, platforms, and service providers offer stability and exposure to multiple therapeutic success stories
• How innovation in automation, analytics and AI is driving scalability and cost reduction across the CGT value chain
• Understanding how investors are rethinking returns by backing the ecosystem – not just the end product